Racial minorities are poorly represented in genomic research databases, raising important questions about whether or not all patients will benefit equally from advances in precision oncology.
African Americans have a 60% higher incidence of prostate cancer and are about 2 times more likely to die from the disease.
Patient outcomes following the diagnosis of multiple myeloma have improved markedly over recent years, but racial and ethnic disparities exist.
In this question-and-answer session, Cancer Therapy Advisor asked Dr Duma about her team's study and minority patient representation in breast cancer studies.
Genetically personalized assessments may optimize treatment by predicting which patients require aggressive treatment.
Alcohol intake is a modifiable risk factor for breast cancer among African American women.
Prostate specific antigen (PSA) levels may be misleading in African American men and a greater workup may be required.
Racial Disparities in the Quality, Cost of Care for Medicare Beneficiaries With Localized Prostate CancerNovember 09, 2015
Black men who receive radical prostatectomy experienced longer wait times, higher costs, and poorer quality care than white men, but no difference in cancer-specific or overall survival rates.
Women in certain racial/ethnic groups are more likely to be diagnosed with more advanced breast cancer.
Hispanics have lower cancer incidence and death rates than non-Hispanic whites.
African American women with breast cancer may have more aggressive tumor biology compared to white women.
Rates of inpatient palliative care consultation remain low and occur close to death irrespective of race/ethnicity.
Age at menarche could play a role in development of estrogen receptor-negative (ER−) breast cancers among African-American women.
Racial disparities exist in post-surgical health-related quality of life (HRQoL) among patients with non-small cell lung cancer (NSCLC).
While breast cancer-specific mortality among older women has improved across all races in recent years, other cause-mortality has not.
Minority patients are less actively involved in surgeon and hospital selection for breast cancer surgery.
Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.
New research finds biological differences in breast cancer tumor type, behavior based on race, ethnicity.
For black women, obesity increases postmenopausal risk of breast cancer by 31 percent.
African American women who have had children and breastfeed have a decreased risk for developing estrogen receptor-negative breast cancer.
Black watchful waiting patients more likely to develop aggressive disease earlier than white patients.
Similar risk reduction seen with brisk walking, vigorous exercise at least seven hours/week.
The breast cancer survival disparity between black and white women in the United States is still a significant problem.
Genomic and epigenomic alterations in PAX gene family linked to racial disparity in survival
Peers can share critical information to encourage annual screenings for cancer.
Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival.
Cancer mortality rates remain higher among African-Americans than among whites, but the gap may be narrowing.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC